These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 26346726)
1. Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. Dale E; Pehrson AL; Jeyarajah T; Li Y; Leiser SC; Smagin G; Olsen CK; Sanchez C CNS Spectr; 2016 Apr; 21(2):143-61. PubMed ID: 26346726 [TBL] [Abstract][Full Text] [Related]
2. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission. Pehrson AL; Jeyarajah T; Sanchez C CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622 [TBL] [Abstract][Full Text] [Related]
4. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Pehrson AL; Sanchez C Drug Des Devel Ther; 2015; 9():603-24. PubMed ID: 25653499 [TBL] [Abstract][Full Text] [Related]
5. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Sanchez C; Asin KE; Artigas F Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186 [TBL] [Abstract][Full Text] [Related]
6. Recent Developments on Future Antidepressant-related Serotonin Receptors. Amidfar M; Kim YK Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919 [TBL] [Abstract][Full Text] [Related]
7. Modulating the serotonin system in the treatment of major depressive disorder. Morrissette DA; Stahl SM CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378 [TBL] [Abstract][Full Text] [Related]
8. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Haddjeri N; Szabo ST; de Montigny C; Blier P Neuropsychopharmacology; 2000 Apr; 22(4):346-56. PubMed ID: 10700654 [TBL] [Abstract][Full Text] [Related]
9. Vortioxetine: a New Treatment for Major Depressive Disorder. Connolly KR; Thase ME Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe. Dong J; De Montigny C; Blier P Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacological properties of vortioxetine and its pre-clinical consequences]. David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038 [TBL] [Abstract][Full Text] [Related]
13. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
14. [Antidepressants, stressors and the serotonin 1A receptor]. Kirilly E; Gonda X; Bagdy G Neuropsychopharmacol Hung; 2015 Jun; 17(2):81-9. PubMed ID: 26192901 [TBL] [Abstract][Full Text] [Related]
15. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Carr GV; Lucki I Psychopharmacology (Berl); 2011 Feb; 213(2-3):265-87. PubMed ID: 21107537 [TBL] [Abstract][Full Text] [Related]
16. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043 [TBL] [Abstract][Full Text] [Related]
17. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ]. Gardier AM; Trillat AC; Malagié I; David D; Hascoët M; Colombel MC; Jolliet P; Jacquot C; Hen R; Bourin M C R Acad Sci III; 2001 May; 324(5):433-41. PubMed ID: 11417564 [TBL] [Abstract][Full Text] [Related]
18. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218 [TBL] [Abstract][Full Text] [Related]
19. VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES. Dziwota E; Olajossy M Acta Pol Pharm; 2016 Nov; 73(6):1433-1437. PubMed ID: 29634095 [TBL] [Abstract][Full Text] [Related]
20. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. Zhong P; Yan Z Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]